Strategic Plan
Study identifies potential colon cancer biomarker
Feb. 11, 2016—A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.
Prostate cancer survivors’ risk of heart disease studied
Feb. 4, 2016—The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.
VICC joins other major cancer centers in HPV vaccine campaign
Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.
Grant spurs research into trauma-induced vision loss
Feb. 4, 2016—Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide.
Successful entrepreneur and innovator chosen to lead new Innovation Center
Feb. 1, 2016—Startup veteran Robert Grajewski has been chosen as the inaugural executive director of the newly created Vanderbilt University Innovation Center.
Findings offer new insight on how cell division proteins work
Jan. 28, 2016—A family of proteins with critical roles in cell division, synaptic transmission and cell migration don’t all function the way scientists thought they did, according to two new studies led by Vanderbilt researchers.
Cochlear implant’s success is music to patient’s ears
Jan. 28, 2016—Sidney Kleinman is living proof that you’re never too old to have your hearing restored.
Autism study links sensory difficulties, serotonin system
Jan. 28, 2016—Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD.
Using MRI to assess myelin health
Jan. 25, 2016—Vanderbilt investigators report an improved model for estimating brain health, using MRI.
Faulty building blocks in DNA
Jan. 22, 2016—An enzyme that builds DNA is able to insert the wrong building blocks, which could generate mutations.
Antibodies may be ‘silver bullet’ for Ebola viruses
Jan. 21, 2016—There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.
New targets for diabetic retinopathy
Jan. 21, 2016—Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.
